If you liked this article you might like

Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers
Akebia Secures Exclusive Access to U.S. Dialysis Patients With Vifor-Fresenius Pact
Group Stink; Good, the Bad and the Ugly: Doug Kass' Views
Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views